CellMEAT is a company that provides protein production services.
CellMEAT has raised $13.2M in total funding. The most recent round was Series A. The last funding was announced in May 2023.
CellMEAT's investors include Strong Ventures, Primer Sazze Partners, Daewoong Pharmaceutical, Primer, Knollwood Investment Advisory.
CellMEAT is headquartered in Seoul, South Korea.
CellMEAT is a company that provides protein production services.
CellMEAT is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CellMEAT — Funding & Investors." VCBacked, May 24, 2023, https://www.vcbacked.co/company/cellmeat. Accessed August 14, 2026.
VCBacked. (2023). CellMEAT — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/cellmeat
{{cite web |title=CellMEAT — Funding & Investors |url=https://www.vcbacked.co/company/cellmeat |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated